Premier Anti-Aging Co., Ltd.
Stock Price Chart
2026/10/09 19:27 UpdatedPrice Trend
2026/10/09 19:27 UpdatedPrice & Trading Details
2026/10/09 19:27 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/10/01Shareholder Composition
Updated 2026/10/01Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Income Statement | |||
| Revenue | ¥33,912M | ¥26,400M | ¥20,359M |
| Gross Profit | ¥26,629M | ¥19,242M | ¥16,100M |
| Operating Income | ¥2,414M | -¥612M | ¥139M |
| Pretax Income | ¥2,587M | -¥641M | -¥880M |
| Net Income | ¥1,424M | -¥733M | -¥1,483M |
| EPS | ¥163.11 | -¥84.17 | -¥170.10 |
| Operating Margin | 7.12% | -2.32% | 0.68% |
| Balance Sheet | |||
| Total Assets | ¥12,300M | ¥12,135M | ¥11,002M |
| Total Equity | ¥8,348M | ¥7,608M | ¥6,122M |
| Total Liabilities | ¥3,952M | ¥4,527M | ¥4,880M |
| Cash | ¥2,973M | ¥4,670M | ¥4,760M |
| Interest-bearing Debt | ¥1,413M | ¥2,260M | ¥2,442M |
| Equity Ratio | 67.87% | 62.69% | 55.64% |
| D/E Ratio | 0.17 | 0.30 | 0.40 |
| Cash Flow | |||
| Operating CF | -¥3,322M | ¥2,422M | ¥425M |
| Investing CF | -¥298M | -¥900M | -¥540M |
| Financing CF | ¥502M | ¥179M | ¥183M |
| Free CF | -¥3,526M | ¥1,644M | -¥395M |
| Efficiency | |||
| ROE | 17.06% | -9.63% | -24.22% |
| ROA | 11.58% | -6.04% | -13.48% |
Latest IR Information
-
Explanation Material on Business Plan and Growth Potential
Focusing on the results for the fiscal year ending July 2026 and the forecast for July 2027, the document outlines a full-scale rollout in the skin care domain centered on Skin for Longevity, expansion of the Recovery Wear business, strengthened...
Read more -
Notice Regarding Director Nomination
As a director nomination, reappointment and appointment of the current four individuals, including Mr. Kiyomatsu, are planned for October 29, 2026.
Read more -
Notice on Differences between Consolidated Full-Year Earnings Forecast for the 2026 July Term and Actual Results
Differences occurred between the full-year consolidated earnings forecast for the 2026 July term and actual results. Net sales were higher than the previous forecast, actual result was 13,883 million yen vs. the previous forecast of 13,500 million yen. Operating income...
Read more -
Financial Summary
For the consolidated net sales for the fiscal year ending July 2026, YoY decline overall; Recovery Business grows, Anti-Aging Business declines. Operating income exceed the revised plan. For 2027/07, company-wide sales are expected to be at the prior year’s level,...
Read more -
Fiscal 2026 July Term Financial Summary [Japanese GAAP] (Consolidated)
For the consolidated results of the 2026 July term, net sales were 13,883 million yen (down 14.1% YoY), operating profit was 494 million yen (down 19.8% YoY), and net income attributable to owners of the parent was 364 million yen...
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥640
Rating Score: - (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Premier Anti-Aging Co., Ltd. engages in the planning, development, import, export, mail order/EC, wholesale, and retail of cosmetics, health foods, and recovery wear in Japan. The company is involved in anti-aging and recovery businesses; and manufactures and sells skin care, hair care, and inner care products. It offers its products under the DUO, CANADEL, Clayence, C+mania, Sinto, Sitrana, Reinca, and Lalaskin brands. The company was incorporated in 2009 and is headquartered in Minato, Japan.
